Furthermore, to confirm productive infection of ASDCs via CD4/CCR5, we demonstrated that the CCR5 inhibitor maraviroc was able to completely block the ability of ASDCs to mediate second phase transfer (Fig 8c). The gene discussed is CCR5; the disease is infection.